Here in glioma cells, Gαi1/3 silencing, by targeted shRNAs, blocked NLGN3-induced RTKs endosomal translocation and subsequent Gab1 activation, without affecting RTK phosphorylation and expression. The gene discussed is NLGN3; the disease is central nervous system cancer.